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SUMMARY
Ex vivo machine perfusion of the liver after cold storage has found to be most
effective if combined with controlled oxygenated rewarming up to (sub)-nor-
mothermia. On disconnection of the warm graft from the machine, most sur-
geons usually perform a cold flush of the organ as protection against the
second warm ischemia incurred upon implantation. Experimental evidence,
however, is lacking and protective effect of deep hypothermia has been chal-
lenged for limited periods of liver ischemia in other models. A first systematic
test was carried out on porcine livers, excised 30 min after cardiac arrest, sub-
jected to 18 h of cold storage in UW and then machine perfused for 90 min
with Aqix-RSI solution. During machine perfusion, livers were gradually
rewarmed up to 20 °C. One group (n = 6) was then reflushed with 4 °C cold
Belzer UW solution whereas the second group (n = 6) remained without cold
flush. All livers were exposed to 45 min warm ischemia at room temperature
to simulate the surgical implantation period. Organ function was evaluated in
an established reperfusion model using diluted autologous blood. Cold reflush
after disconnection from the machine resulted in a significant increase in bile
production upon blood reperfusion, along with a significant reduction in
transaminases release alanine aminotransferase and of the intramitochondrial
enzyme glutamate dehydrogenase. Interestingly, free radical-mediated lipid
peroxidation was also found significantly lower after cold reflush. No differ-
ences between the groups could be evidenced concerning histological injury
and recovery of hepatic energy metabolism (tissue content of adenosine
triphosphate). Post-machine preservation cold reflush seems to be beneficial in
this particular setting, even if the organs are warmed up only to 20 °C, without
notion of adverse effects, and should therefore be implemented in the protocol.
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Introduction
Liver transplantation is often the last therapeutic option
for end-stage liver diseases, like cirrhosis or hepatic
cancer. However, the steadily increasing demand on
donor organ grafts is driving the growing use of mar-
ginal grafts originating from older donors or patients
with disease condition [1].
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In order to cope with the reduced resilience of such
organs towards ischemic preservation, dynamic preser-
vation and reconditioning methods have found their
way into clinical practice of organ storage.
These mainly focus on ex vivo machine perfusion of
the retrieved organ, most often performed in hypother-
mia using perfusion solutions adapted for organ perfu-
sion at low temperatures [2,3].
It was also found that main tissue damage does not
occur during static storage, but rather evolves upon
reestablishment of the blood circulation upon surgical
revascularization fostering the postponed use of machine
perfusion even after preceding cold storage and easy trans-
portation of the graft conventionally stored on ice [4–7].
Subsequently, ex vivo organ perfusion had been tried
at higher temperatures, in order to enhance metabolic
(re-)equilibration of tissue homeostasis and to improve
graft quality assessment prior to implantation. Thus,
normothermic [8–10] or subnormothermic [11–13] per-
fusion of the liver has been proposed as a method of
preservation or beneficial adjunct following usual cold
storage in clinical liver transplantation.
Recently, it has been suggested that abrupt rise in
temperature after hypothermic preservation may repre-
sent a genuine trigger of tissue injury, aggravating mito-
chondrial dysfunction and negatively affecting graft
function upon reperfusion [14]. As a consequence, slow
warming up of the cold liver while being perfused on
an ex vivo perfusion machine—the so called “controlled
oxygenated rewarming” has been proposed to circum-
vent this “rewarming injury” [15].
Clinical transplantation procedures, however, com-
prise a mandatory phase of ischemia at ambient body
temperature during surgical implantation, during which
the graft is not actively oxygenated.
This second warm ischemia between machine perfu-
sion and actual reperfusion in vivo upon reestablish-
ment of blood circulation is usually dealt with by an
additional cold organ flush at the end of machine per-
fusion with the aim to cool down the organ and thereby
protect the graft from ischemic injury.
However, experimental evidence for this habit to be
beneficial is lacking and it is still elusive if this cold
flush contributes to tissue protection or if additional
temperature variations could have negative impacts on
tissue recovery. Earlier studies already analyzed the
effect of intraischemic temperatures on later organ func-
tion in rat livers and found that mild hypothermia at
32–26 °C already diminishes the oxidative stress effec-
tively, which the authors attribute to a reduced initial
production of reactive oxygen species [16].
Moreover, static organ storage at elevated tempera-
tures has already been proposed with Aqix-RSI solution
as useful medium and might thus render it reasonable
to avoid a final cold flush of the machine perfused
organ [17,18].
Therefore, the present study was aimed to systemati-
cally investigate the usefulness of an initial cold flush
prior to second warm ischemia during implantation as
strategy to protect the liver graft from further injurious
events.
Methods
All experiments were performed in accordance with the
federal law regarding the protection of animals. The
principles of laboratory animal care (NIH publication
no. 85-23, revised 1985) were followed.
Livers of female German Landrace pigs weighing
between 25 and 30 kg were premedicated with intramus-
cular injection of ketamine (20 mg/kg), xylazine (2 mg/
kg), and atropine (0.25 mg/kg). General anesthesia on
the operating table was induced by intravenous bolus of
midazolam (0.5 mg/kg) and fentanyl (10 lg/kg). On
intubation, anesthesia was maintained by continuous
mechanical ventilation with isoflurane. After liver dissec-
tion, cardiac standstill was induced by bleeding to death
and injection of 20 ml potassium chloride (7.5%). Blood
was collected in commercial bags (Composelect; Fresenius
Kabi, Bad Homburg, Germany) for later experiments.
Thirty minutes after cardiocirculatory standstill, the
liver was rinsed in situ by gravity with 2 l of 4 °C cold
UW-solution (Bridge to Life, London, UK). Afterward,
livers were removed and hepatic artery and portal vein
were cannulated on the back table and flushed with
another liter UW-solution at 4 °C. Livers were finally
cold stored overnight in UW-solution for 18 h.
After static cold storage (CS), livers were subjected to
oxygenated machine perfusion in a liver assist system as
described previously [19]. Livers were perfused with 2 l
Aqix-RSI solution, oxygenated with 95% O2 and 5%
CO2 for 90 min. Temperature was controlled and
gradually increased from 8 °C up to 20 °C within the
first 60 min and kept constant for the remaining
30 min. Portal vein and hepatic artery were connected
to separate perfusion circuits with integrated hollow
fiber oxygenators, perfusion pumps, and pressure sen-
sors. The hepatic artery was perfused in a pulsatile
mode at a pressure of 25 mmHg. Perfusion of the por-
tal vein was applied continuously at 3 mmHg.
Prior to reperfusion, grafts were randomly assigned
to one of the following groups (n = 6, resp.):
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1 At the end of ex vivo MP, livers were rinsed with
1 l cold UW- solution; afterward, grafts were
exposed to room temperature for 45 min to simu-
late the implantation period.
2 Livers were exposed to 45 min at room tempera-
ture without additional cold flush after MP.
For the flush group, liver temperature measurements
were done after cold flush and at the end of the 45 min
implantation interval. All livers were flushed with bal-
anced salt solution at room temperature immediately
prior to reperfusion. Afterward, functional recovery of
the grafts was tested using an established in vitro reper-
fusion model as described previously [20,21].
Isolated liver reperfusion model
In brief, livers were transferred to a moist chamber and
perfused at 37 °C with autologous blood that was
retrieved during surgical intervention and stored over-
night in commercial blood bags. One liter of blood was
diluted with 500 ml Gelafundin 5% and supplemented
with Ca2Cl and sodium bicarbonate to adjust physiolog-
ical calcium concentration and pH.
Temperature was controlled by a circulating thermostat
and perfusate was oxygenated by a temperature controlled
hollow fiber oxygenator (Hilite LT 1000; Medos, Stolberg,
Germany). Gas flow was adapted to physiological blood
gas values (pO2 150–200 mmHg, pCO2 40–60 mmHg).
Hepatic artery was perfused at a physiological pressure of
80 mmHg, controlled by an integrated servo-controlled
roller pump and a pressure sensor connected to the inflow
line immediately prior to the liver artery. Portal vein was
perfused constantly at 0.9 ml/g/min driven by a centrifugal
blood pump and portal perfusion pressure was controlled
by a water column connected to the inflow tract.
During perfusion, livers were continuously supplied
with a mixture of 80 ml glucose 5%, 20 ml amino acids
(RPMI 509), 10 IU insulin, and 1 mg taurocholic acid,
infused to the perfusion circuit at 15 ml/min to provide
nutrient support and substrate for bile production.
Analytical procedures
Perfusion resistance of hepatic artery and portal vein
was calculated using independently measured flow and
pressure values in relation to liver mass, expressed in
mmHg * l * min1 * 100 g1.
Oxygen partial pressure, Hb, and perfusate concen-
trations of lactate and glucose were measured in a pH-
blood gas analyzer (ABL 815flex acid-base laboratory;
Radiometer, Copenhagen, Denmark).
Serum enzyme activities of alanine aminotransferase
(ALT) and glutamate dehydrogenase (GLDH) were
determined in a routine fashion at the laboratory center
of the University Hospital.
The common bile duct was cannulated using poly-
ethylene tubing and bile was collected throughout the
reperfusion period. Hepatic bile production was calcu-
lated as ml/kg/h.
Oxygen-free radical-induced tissue injury was approx-
imated by the amount of thiobarbituric acid-reactive
substances (TBARS), breakdown products of lipid per-
oxidation (LPO), released into the circulation upon
reperfusion. TBARS were evaluated by fluorimetry from
deproteinized serum samples using the adduct forma-
tion with thiobarbituric acid as detailed elsewhere [22].
Energetic status
Tissue specimens for assessment of high-energy phos-
phates were taken with precooled steel tongs, immersed
in liquid nitrogen, and stored at 80 °C for later analy-
sis. Wet weight of the frozen tissue samples was mea-
sured before they were lyophilized in a vacuum freezer
(60 °C; <0.025 mbar) for at least 7 days to evaporate
tissue water. Freeze-dried specimens were weighed again
and proteins were extracted with perchloric acid as
described previously [7]. Aliquots of the neutralized
supernatant were used for the determination of adeno-
sine triphosphate (ATP) by means of a commercial test
kit (Abcam, Cambridge, UK) according to the manufac-
turer’s instructions. The results were corrected for the
respective dry weight to wet weight ratio of the tissue
samples and expressed as lmol/g dry weight (dw).
Histology
Liver tissue samples were obtained at the end of experi-
ments and were fixed in 4% buffered formalin. Paraffin
embedding, tissue sections, and hematoxylin–eosin
(HE) staining were performed in the institute of pathol-
ogy of university hospital Essen using standard proce-
dures. Morphological evaluation of parenchymal
integrity was done at 200-fold magnification. The extent
of injury was semiquantitatively graded in a four-stage
system ranging from 0 to 3 in a blinded fashion by two
independent investigators.
Statistics
All values are expressed as means  SEM for n = 6 ani-
mals per group. Differences between groups were tested
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by unpaired, two-sided t-test, unless otherwise indi-
cated. Statistical significance was set at P < 0.05.
Results
Influence of cold reflush on liver core temperature
Liver temperature after machine perfusion at 20 °C
declined to 12.9  0.3 °C after reflush with 1 l of cold
UW-solution. During the ensuing 45 min of simulated
second warm ischemia at room temperature, liver core
temperature rose again to attain a mean value of
16.6  0.3 °C. Temperature in the untreated group
during the second warm ischemia remained around
room temperature.
Cold flush reduces liver enzyme release
During reperfusion, perfusate samples were collected
every 30 min and enzyme releases of ALT and GLDH
during reperfusion were taken as general parameters of
hepatocellular injury of the liver.
The release of liver enzymes was observed to steadily
increase during 3 h reperfusion in both groups. However,
leakage of cytosolic ALT as well as of the intramitochondrial
GLDH could be significantly reduced by initial cold flush
prior to second warm ischemia, as illustrated in Fig. 1.
Cold flush improves hepatic bile production
During experiments, hepatic bile production was
observed as representative marker for hepatocyte func-
tional integrity. Bile secretion was observed throughout
3 h reperfusion period (Fig. 2). The absence of cold flush
after ex vivo MP diminished bile production of hepato-
cytes during reperfusion as presented in Fig. 2. A cold
organ flush prior to second warm ischemia resulted in a
significant increase for more than 30% of bile produced
during the second half of perfusion time than observed
for the no flush group.
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Figure 1 Release of liver enzymes during reperfusion after 18 h static cold storage and 90 min machine perfusion with controlled oxygenated
rewarming up to 20 °C. Comparison of cold flush (Flush, n = 6) versus no-flush (noFlush, n = 6) at the end of MP prior to 45 min implantation
period. AST, aspartate-aminotransferase; GLDH, glutamate dehydrogenase. Mean  SEM, *P < 0.05.















Figure 2 Hepatic bile production during 3 h reperfusion after 18 h
static cold storage and 90 min machine perfusion with controlled
oxygenated rewarming up to 20 °C. Comparison of cold flush (Flush,
n = 6) versus no-flush (noFlush, n = 6) at the end of controlled oxy-
genated rewarming prior to 45 min implantation period.















Figure 3 Lipid peroxidation products at the end of 3 h reperfusion.
Cold stored livers were subjected to 90 min ex vivo machine perfu-
sion with controlled oxygenated rewarming up to 20 °C. Comparison
of cold flush (Flush, n = 6) versus no-flush (noFlush, n = 6) at the
end of controlled oxygenated rewarming prior to 45 min implanta-
tion period. Mean  SEM, *P < 0.05.
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Cold flush reduces oxidative stress
Oxidative stress incurred by the livers during the respec-
tive protocols was assessed by the measurement of free
radical-mediated LPO. LPO was analyzed in perfusate
samples, collected at the end of 3 h reperfusion, and is
shown in Fig. 3. Cold organ flush resulted in signifi-
cantly lower LPO values than the control group without
additional flush at the end of MP.
Histology score
Structural alterations of the livers were analyzed using
formalin fixed liver sections that were stained with
hematoxylin–eosin (HE). Both treatment groups exhib-
ited only moderate alterations of liver morphology and
there were no obvious differences between the two
groups (Fig. 4). Quantification of structural alterations
yielded injury score values of 1.36  0.24 for the cold
flush group and 1.44  0.15 for the control group
without flush prior to the second warm ischemia
(means  SEM, differences being not significant).
Energetic recovery
Recovery of hepatic energy metabolism was assessed by
tissue content of ATP at the end of the experiment as
shown in Fig. 5. Flushed livers show by tendency more
ATP production, but differences did not reach statistical
significance.
Discussion
Recent upsurge of normothermic ex vivo graft perfusion
prior to transplantation has brought up the question
how to deal with the warm liver once disconnected
from the perfusion machine.
In the case of subnormothermic machine perfusion,
which has proven comparably effective by several groups
[23–25], the need for secondary cooling of the previ-
ously rewarmed graft becomes even more controversial.
The perfusion solution used in this study—Aqix RSI
—has already been proposed as useful medium for flush
and static preservation of kidneys at 30 °C [17,18].
However, the results of the present study argue in favor
of a cold flush to protect the organ during the second
warm ischemia in the setting of engraftment.
Previous research has suggested that the thermal tran-
sit from cold to warm may, on its own, represent a
potential inducer of cell injury [14,26]. This “rewarming
injury” depends on cellular alterations occurring during
hypothermia and seems to be mediated by iron-depen-
dent formation of reactive oxygen species [27]. In this
context, it might be of importance that the cold flush
only lowers the core temperature of the livers but does
not result in a severe cooling down to strictly
noFlush Flush
Figure 4 Liver tissue morphology at the end of 3 h reperfusion. Cold stored livers were subjected to 90 min ex vivo machine perfusion with
controlled oxygenated rewarming up to 20 °C. Comparison of cold flush (Flush, n = 6, right) versus no-flush (noFlush, n = 6, left) at the end
















Figure 5 Tissue content of adenosine triphosphate at the end of 3 h
reperfusion. Before reperfusion livers were subjected to 90 min con-
trolled oxygenated rewarming to 20 °C with (n = 6) or without addi-
tional cold flush (n = 6) at the end of machine perfusion.
Mean  SEM.
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hypothermic values of about 4 °C. It is known from sys-
tematic investigations in isolated cells that cellular
release of LDH upon rewarming from the cold only
takes place if the cells have previously been kept at tem-
peratures below 13–16 °C [28] and if this exposure has
lasted for longer time periods. Thus, the additional only
mild thermal transition, encountered upon cold reflush
of the organ, will conjecturally not be associated with
notable side effects either. Moreover, observations of
Khandoga et al. [16], using an in situ mouse model of
partial liver ischemia, have shown, that the increase in
tissue levels of reactive oxygen species mediated lipid
peroxides was significantly reduced by lowering the
intraischemic temperature to 26 °C, but completely
abolished by intraischemic temperatures of 15 °C or
less.
In line with these observations, we have found a sig-
nificant reduction in lipid peroxide generation by
implementing a cold flush of the organ prior to second
warm ischemia and the small decrease in liver tempera-
ture from 20 to 13–16 °C might hence have been suffi-
cient for a notable reduction in free radical generation.
This is also translated into a significant reduction in
consecutive liver injury, as evaluated by enzyme loss
and improved bile production, but differences were not
as prominent as to impact liver energetics or to induce
morphological changes.
Interestingly, previous work of Biberthaler is in
apparent contrast to our findings. The study showed an
almost complete prevention of disintegration of hepatic
parenchyma and release of transaminases after in situ
warm ischemia of mouse livers for 90 min if parenchy-
mal temperature was lowered to only 26 °C [29]. No
further protection was provided by more intense cool-
ing of the organ. The different impact on transaminase
release between our study and the results of Biberthaler
et al. might be due to species differences or the diver-
gences in the model as a healthy, blood perfused organ
rendered ischemic by clamping the afferent vessels
might react slightly different to a prealtered isolated
perfused liver.
The model used in our study has been chosen as to
resemble to the human situation as close as possible.
Only large size organs will thermodynamically reflect a
core temperature equilibration pattern similar to the
clinical situation. Pilot investigations on rat livers
showed an unrepresentatively swift passive rewarming
after rinse with cold media (B. L€uer, personal commu-
nications) and were not adequate to delineate differ-
ences between reflushed and untreated livers.
The present experiments only addressed the subnor-
mothermic situation, but clearly demonstrated an over-
all benefit obtained by reflushing the livers with cold
media prior to second warm ischemia.
It can hence conjectured that the implementation of
a secondary cold flush will also be useful after machine
perfusion at normothermia in a comparable setting.
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